AVE vs MVP

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

AVE

AVECHO FPO [AVE]

55MEDIUM

MVP

MEDICALDEV FPO [MVP]

62MEDIUM-HIGH

Score Breakdown

AVE MVP
Technical
55
68
Catalyst
59
50
Sentiment
50
50
Fundamental
44
95
Momentum
71
51
Risk Gate
45
50

Key Metrics

AVE Metric MVP
$77.3MMarket Cap$52.9M
3.9MAvg Volume (20d)214K
N/AShort InterestN/A
$0.02752-Week High$0.765
$0.00552-Week Low$0.365
-4.6%Daily Change+2.2%
$0.021Reference Price$0.460
-268.2%ROE+1.1%
N/AProfit Margin+1.5%

Active Signals

AVE Signals

●Drifting lower — down 8.7% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Adequate cash runway (7 quarters)
●Very high P/S ratio (104.8x)
●Revenue in sharp decline (-89%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)

MVP Signals

●Stochastic is deep in oversold territory — bounce conditions forming
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (1.2x)
●Moderate revenue growth (+10%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare AVE and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BLS vs IMM →CGS vs RHT →CUV vs SOM →IIQ vs IMM →IMM vs LDX →
AVE Full Analysis → MVP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).